Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
17.88
+0.08 (0.45%)
At close: Oct 13, 2026, 4:00 PM EDT
18.05
+0.17 (0.95%)
After-hours: Oct 13, 2026, 7:57 PM EDT
Legend Biotech Employees
Legend Biotech had 2,965 employees as of December 31, 2025. The number of employees increased by 356 or 13.65% compared to the previous year. That makes Legend Biotech the 8,003rd largest employer in the world and 1,452nd in the United States.
Employees
2,965
Change (1Y)
356
Growth (1Y)
13.65%
Revenue / Employee
$428,803
Profits / Employee
-$30,860
Market Cap
3.46B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,965 | 356 | 13.65% |
| Dec 31, 2024 | 2,609 | 783 | 42.88% |
| Dec 31, 2023 | 1,826 | 436 | 31.37% |
| Dec 31, 2022 | 1,390 | 319 | 29.79% |
| Dec 31, 2021 | 1,071 | 189 | 21.43% |
| Dec 31, 2020 | 882 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Acadia Pharmaceuticals | 798 |
| Arcus Biosciences | 601 |
| Xenon Pharmaceuticals | 370 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Relay Therapeutics | 202 |
| Celcuity | 155 |
LEGN News
- 16 hours ago - Legend Biotech price target lowered to $68 from $74 at Barclays - TheFly
- 4 days ago - Legend Biotech price target lowered to $33 from $35 at JPMorgan - TheFly
- 5 days ago - Legend Biotech price target lowered to $56 from $58 at RBC Capital - TheFly
- 12 days ago - Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma - GlobeNewsWire
- 18 days ago - Legend Biotech announces five-year follow-up data from Cartitude-2 Cohort A - TheFly
- 18 days ago - Legend Biotech Presents CARVYKTI Data Showing Half of Patients with RRMM Remained Progression-Free and Alive Five Years After a Single Infusion - GlobeNewsWire
- 4 weeks ago - Legend Biotech taps Novartis veteran Zhang as CEO - Reuters
- 4 weeks ago - Legend Biotech appoints Ingrid Zhang as CEO - TheFly